IN THE NEWS
Infusion Providers Alliance Submits Legislative Recommendations to House Republican Healthy Futures Taskforce
IPA is the leading voice for in-office and freestanding infusion providers, representing over 1,000 facilities in 43 states, Our mission is to serve as a thought leader and educate on issues critical to safeguarding, supporting and strengthening provider directed, [...]
IPA Comments on Aduhelm NCD
The Infusion Providers Alliance (IPA) is pleased to provide comments regarding the Center for Medicare and Medicaid Services (CMS) National Coverage Determination for Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimer's Disease.
IPA Newsletter
Update from Doug Ghertner, President of IPA It is hard to believe that it has been almost a year since we founded and launched the Infusion Providers Alliance (IPA). We started with just a few companies and now have 10 [...]
IPA Engages 4 MACs on Recent Downcoding of Complex Drug Infusions
The Infusion Providers Alliance (“IPA”) writes to request a meeting to share our concerns regarding CGS’s recent reimbursement treatment of certain intravenous drug administration services for complex, rare, and chronic diseases,1 which went into effect on April 8, 2021.
In the States
The Infusion Providers Alliance (IPA) is the leading voice for in-office and freestanding ambulatory infusion care, representing more than 870 community-based, non-hospital providers across the United States. Our members are committed to preserving the integrity of the provider-patient relationship in [...]